India's Shasun Pharmaceuticals has entered into a collaboration with Nanoparticle Biochem, Inc. (NBI) to develop a nanoparticle radioactive medicine NBI-29 to treat prostate cancer.
OGX-011, an experimental anti-clusterin agent, could almost double the life expectancy of patients with advanced prostate cancer, says a Canadian study.
India's biotechnology sector is expected to touch as much as $8 billion growing at a pace of 20% per annum for the next five years, says a recent survey report titled 'India Life Sciences: Vision 2015' prepared by the Confederation of Indian Industries (CII) and Yes Bank Knowledge Report .
CH-4051, an oral therapy to treat rheumatoid arthritis developed by Chelsea Therapeutics, has shown promise in early phase trials.
India's Glenmark Pharma may soon start human testing of its a new pain drug lead compound code-named GRC 17536, the company announced.
Low-cost generic versions of Baraclude (entecavir) for the hepatitis B treatment have been launched by 2 more Indian companies, indicating a possible reduction in prices.
Teenage smokers have been declining sharply in the US in the recent years by more than 10% among the high schoolers since the 10 years, says a government study.
Tasimelteon, an investigational drug being tested by Vanda Pharmaceuticals Inc, could help totally blind people sleep better.
A small daily dose of upto 75 mg of aspirin can significantly reduce hypertension-related complications like pre-eclampsia, recommends the National Institute for Health and Clinical Excellence (NICE).
PCV7, a vaccine against seven strains of bacteria causing pneumococcal disease, may bring down cases of bacterial pneumonia in babies, a new study has found.